$GMED
GLOBUS MEDICAL INC

2015 Q4 Form 10-Q Financial Statement

#000123783115000060 Filed on November 04, 2015

View on sec.gov

Income Statement

Concept 2015 Q4 2015 Q3 2014 Q3
Revenue $142.6M $137.0M $117.8M
YoY Change 10.7% 16.3% 9.89%
Cost Of Revenue $34.60M $32.93M $27.69M
YoY Change 10.54% 18.93% 9.37%
Gross Profit $107.6M $104.1M $90.10M
YoY Change 10.38% 15.5% 10.05%
Gross Profit Margin 75.5% 75.96% 76.49%
Selling, General & Admin $49.60M $52.17M $46.99M
YoY Change 3.98% 11.03% 2.81%
% of Gross Profit 46.08% 50.13% 52.15%
Research & Development $9.200M $9.250M $8.146M
YoY Change 9.52% 13.55% 24.03%
% of Gross Profit 8.55% 8.89% 9.04%
Depreciation & Amortization $6.400M $6.100M $5.400M
YoY Change 12.28% 12.96% 12.5%
% of Gross Profit 5.95% 5.86% 5.99%
Operating Expenses $60.30M $63.39M $55.18M
YoY Change 7.49% 14.88% 5.36%
Operating Profit $47.35M $40.68M $34.92M
YoY Change 14.3% 16.47% 18.37%
Interest Expense $100.0K $100.0K
YoY Change
% of Operating Profit 0.21% 0.25%
Other Income/Expense, Net $100.0K $253.0K -$124.0K
YoY Change -150.0% -304.03% -162.94%
Pretax Income $56.20M $40.93M $34.80M
YoY Change 42.28% 17.61% 17.17%
Income Tax $18.60M $14.45M $11.74M
% Of Pretax Income 33.1% 35.3% 33.73%
Net Earnings $37.60M $26.48M $23.06M
YoY Change 36.05% 14.83% 13.55%
Net Earnings / Revenue 26.37% 19.33% 19.58%
Basic Earnings Per Share $0.39 $0.28 $0.24
Diluted Earnings Per Share $0.39 $0.28 $0.24
COMMON SHARES
Basic Shares Outstanding 95.24M shares 95.14M shares 94.40M shares
Diluted Shares Outstanding 96.12M shares 95.48M shares

Balance Sheet

Concept 2015 Q4 2015 Q3 2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $281.0M $238.6M $298.8M
YoY Change 22.87% -20.15% 40.22%
Cash & Equivalents $57.65M $50.50M $169.4M
Short-Term Investments $220.9M $188.1M $129.3M
Other Short-Term Assets $72.20M $76.40M $44.00M
YoY Change 4.49% 73.64% 14.29%
Inventory $105.3M $105.7M $77.43M
Prepaid Expenses
Receivables $77.68M $77.60M $62.60M
Other Receivables $8.700M $8.000M $2.100M
Total Short-Term Assets $544.8M $506.3M $484.8M
YoY Change 15.91% 4.43% 26.0%
LONG-TERM ASSETS
Property, Plant & Equipment $114.7M $106.2M $66.06M
YoY Change 65.16% 60.73% 3.85%
Goodwill $91.96M $91.96M $18.37M
YoY Change 72.88% 400.57% 19.52%
Intangibles $33.24M $33.64M $29.14M
YoY Change -3.73% 15.43% 217.11%
Long-Term Investments $48.80M $61.50M $47.00M
YoY Change -35.19% 30.85% -7.3%
Other Assets $590.0K $1.049M $1.025M
YoY Change -39.49% 2.34% -5.09%
Total Long-Term Assets $289.3M $294.4M $161.6M
YoY Change 23.89% 82.12% 15.52%
TOTAL ASSETS
Total Short-Term Assets $544.8M $506.3M $484.8M
Total Long-Term Assets $289.3M $294.4M $161.6M
Total Assets $834.1M $800.7M $646.4M
YoY Change 18.56% 23.86% 23.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $15.97M $16.36M $9.703M
YoY Change 0.42% 68.59% 9.32%
Accrued Expenses $53.77M $64.17M $55.61M
YoY Change -12.57% 15.4% 25.21%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $82.69M $94.42M $72.76M
YoY Change -7.52% 29.77% 24.42%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.699M $3.400M $2.790M
YoY Change -48.83% 21.86% -21.85%
Total Long-Term Liabilities $1.699M $3.400M $2.790M
YoY Change -48.83% 21.86% -21.85%
TOTAL LIABILITIES
Total Short-Term Liabilities $82.69M $94.42M $72.76M
Total Long-Term Liabilities $1.699M $3.400M $2.790M
Total Liabilities $118.8M $126.7M $92.63M
YoY Change 0.58% 36.83% 21.41%
SHAREHOLDERS EQUITY
Retained Earnings $524.6M $487.0M $384.1M
YoY Change 27.39% 26.77% 28.77%
Common Stock $94.00K
YoY Change 1.08%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $715.3M $673.9M $553.8M
YoY Change
Total Liabilities & Shareholders Equity $834.1M $800.7M $646.4M
YoY Change 18.56% 23.86% 23.21%

Cashflow Statement

Concept 2015 Q4 2015 Q3 2014 Q3
OPERATING ACTIVITIES
Net Income $37.60M $26.48M $23.06M
YoY Change 36.05% 14.83% 13.55%
Depreciation, Depletion And Amortization $6.400M $6.100M $5.400M
YoY Change 12.28% 12.96% 12.5%
Cash From Operating Activities $46.10M $30.10M $35.60M
YoY Change 2205.0% -15.45% 6.27%
INVESTING ACTIVITIES
Capital Expenditures -$14.20M -$11.50M -$3.500M
YoY Change 56.04% 228.57% -36.36%
Acquisitions
YoY Change
Other Investing Activities -$23.80M -$11.30M -$300.0K
YoY Change -71.08% 3666.67% -98.67%
Cash From Investing Activities -$38.00M -$22.80M -$3.800M
YoY Change -58.42% 500.0% -86.48%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.100M 1.700M 900.0K
YoY Change -152.38% 88.89% -77.5%
NET CHANGE
Cash From Operating Activities 46.10M 30.10M 35.60M
Cash From Investing Activities -38.00M -22.80M -3.800M
Cash From Financing Activities -1.100M 1.700M 900.0K
Net Change In Cash 7.000M 9.000M 32.70M
YoY Change -108.02% -72.48% 247.87%
FREE CASH FLOW
Cash From Operating Activities $46.10M $30.10M $35.60M
Capital Expenditures -$14.20M -$11.50M -$3.500M
Free Cash Flow $60.30M $41.60M $39.10M
YoY Change 443.24% 6.39% 0.26%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
dei Document Period End Date
DocumentPeriodEndDate
2015-09-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001237831
CY2015Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
95235193 shares
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
GLOBUS MEDICAL INC
CY2014Q4 gmed Accrued Liabilities Legal And Other Settlements And Expenses
AccruedLiabilitiesLegalAndOtherSettlementsAndExpenses
27686000 USD
CY2015Q3 gmed Accrued Liabilities Legal And Other Settlements And Expenses
AccruedLiabilitiesLegalAndOtherSettlementsAndExpenses
26172000 USD
CY2014Q4 gmed Business Acquisition Liabilities Current
BusinessAcquisitionLiabilitiesCurrent
6081000 USD
CY2015Q3 gmed Business Acquisition Liabilities Current
BusinessAcquisitionLiabilitiesCurrent
13342000 USD
CY2014Q4 gmed Business Acquisition Liabilities Noncurrent
BusinessAcquisitionLiabilitiesNoncurrent
20195000 USD
CY2015Q3 gmed Business Acquisition Liabilities Noncurrent
BusinessAcquisitionLiabilitiesNoncurrent
20732000 USD
CY2014Q4 gmed Intangible Assets Gross
IntangibleAssetsGross
36305000 USD
CY2015Q3 gmed Intangible Assets Gross
IntangibleAssetsGross
36580000 USD
gmed Number Of Product Categories
NumberOfProductCategories
2
gmed Payment Of Business Acquisition Liabilities
PaymentOfBusinessAcquisitionLiabilities
900000 USD
gmed Payment Of Business Acquisition Liabilities
PaymentOfBusinessAcquisitionLiabilities
900000 USD
CY2015Q3 gmed Share Based Compensation Number Of Stock Plans
ShareBasedCompensationNumberOfStockPlans
3
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
15904000 USD
CY2015Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
16358000 USD
CY2014Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
5359000 USD
CY2015Q3 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
0 USD
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
75430000 USD
CY2015Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
77596000 USD
CY2014Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
569000 USD
CY2015Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
550000 USD
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
61499000 USD
CY2015Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
64169000 USD
CY2014Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
3872000 USD
CY2015Q3 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
6378000 USD
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
118544000 USD
CY2015Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
134108000 USD
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1009000 USD
CY2014Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1307000 USD
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1657000 USD
CY2015Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1738000 USD
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
175242000 USD
CY2015Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
188603000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7075000 USD
us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
1973000 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1518000 shares
CY2014Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1661000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5211000 USD
CY2015Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2266000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6935000 USD
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1647000 USD
CY2015Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2224000 USD
CY2014Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1660000 shares
CY2015Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3234000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3118000 shares
CY2014Q4 us-gaap Assets
Assets
703547000 USD
CY2015Q3 us-gaap Assets
Assets
800661000 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
470025000 USD
CY2015Q3 us-gaap Assets Current
AssetsCurrent
506308000 USD
CY2014Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
146439000 USD
CY2015Q3 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
188101000 USD
CY2014Q4 us-gaap Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
75347000 USD
CY2015Q3 us-gaap Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
61525000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
89962000 USD
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
169449000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
82265000 USD
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
50501000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
79487000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-31764000 USD
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
785000000 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
94705743 shares
CY2015Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
95225155 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
94705743 shares
CY2015Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
95225155 shares
CY2014Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
22621000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
64549000 USD
CY2015Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
26432000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
75102000 USD
CY2014Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
27686000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
79581000 USD
CY2015Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
33052000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
97738000 USD
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-5115000 USD
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-4115000 USD
CY2014Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
40062000 USD
CY2015Q3 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
43918000 USD
CY2014Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
5166000 USD
CY2015Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
8193000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
16057000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
17669000 USD
CY2014Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.24
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.69
CY2015Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.28
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.79
CY2014Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.24
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.68
CY2015Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.28
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.78
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
45000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
117000 USD
CY2014Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.337
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.346
CY2015Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.353
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.355
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
19933000 USD
CY2015Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
19647000 USD
CY2014Q3 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0 USD
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0 USD
CY2015Q3 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
140000 USD
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
140000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
4044000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
1973000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
4044000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
1973000 USD
CY2014Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1776000 USD
CY2015Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2945000 USD
CY2014Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-388000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-444000 USD
CY2015Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-205000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-869000 USD
CY2014Q4 us-gaap Goodwill
Goodwill
53196000 USD
CY2015Q3 us-gaap Goodwill
Goodwill
91964000 USD
CY2014Q3 us-gaap Gross Profit
GrossProfit
90101000 USD
us-gaap Gross Profit
GrossProfit
265989000 USD
CY2015Q3 us-gaap Gross Profit
GrossProfit
103940000 USD
us-gaap Gross Profit
GrossProfit
304428000 USD
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
34799000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
99164000 USD
CY2015Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
40928000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
116572000 USD
CY2014Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11738000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
34317000 USD
CY2015Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14447000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
41389000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
36362000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
45955000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
3855000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
6042000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
12535000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
16998000 USD
CY2014Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
5772000 USD
CY2015Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
7995000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2253000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2812000 USD
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
1289000 USD
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-5359000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
886000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3468000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
4378000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-275000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1325000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1368000 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
0 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
2015000 USD
CY2014Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1076000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1267000 shares
CY2015Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
981000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1056000 shares
CY2014Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
34529000 USD
CY2015Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
33635000 USD
CY2014Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
181000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
577000 USD
CY2015Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
342000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
898000 USD
us-gaap Interest Paid
InterestPaid
32000 USD
us-gaap Interest Paid
InterestPaid
9000 USD
CY2014Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
79608000 USD
CY2015Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
87487000 USD
CY2014Q4 us-gaap Inventory Net
InventoryNet
90945000 USD
CY2015Q3 us-gaap Inventory Net
InventoryNet
105705000 USD
CY2014Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
8847000 USD
CY2015Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
10649000 USD
CY2014Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
2490000 USD
CY2015Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
7569000 USD
us-gaap Inventory Write Down
InventoryWriteDown
5439000 USD
us-gaap Inventory Write Down
InventoryWriteDown
7122000 USD
us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
2073000 USD
us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
2352000 USD
CY2014Q4 us-gaap Liabilities
Liabilities
118093000 USD
CY2015Q3 us-gaap Liabilities
Liabilities
126744000 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
703547000 USD
CY2015Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
800661000 USD
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
313000 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
89412000 USD
CY2015Q3 us-gaap Liabilities Current
LiabilitiesCurrent
94419000 USD
CY2014Q3 us-gaap Loss Contingency Accrual Provision
LossContingencyAccrualProvision
46000 USD
us-gaap Loss Contingency Accrual Provision
LossContingencyAccrualProvision
3899000 USD
CY2015Q3 us-gaap Loss Contingency Accrual Provision
LossContingencyAccrualProvision
27000 USD
us-gaap Loss Contingency Accrual Provision
LossContingencyAccrualProvision
433000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10788000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5386000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8573000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-115144000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
77227000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
77877000 USD
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
23061000 USD
us-gaap Net Income Loss
NetIncomeLoss
64847000 USD
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
26481000 USD
us-gaap Net Income Loss
NetIncomeLoss
75183000 USD
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2014Q3 us-gaap Operating Expenses
OperatingExpenses
55178000 USD
us-gaap Operating Expenses
OperatingExpenses
167271000 USD
CY2015Q3 us-gaap Operating Expenses
OperatingExpenses
63265000 USD
us-gaap Operating Expenses
OperatingExpenses
188203000 USD
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
34923000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
98718000 USD
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
40675000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
116225000 USD
CY2014Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5288000 USD
CY2015Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5913000 USD
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
975000 USD
CY2015Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1049000 USD
CY2014Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-422000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-290000 USD
CY2015Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-124000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-184000 USD
us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-305000 USD
us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-84000 USD
CY2014Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-440000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-298000 USD
CY2015Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-49000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-81000 USD
CY2014Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-18000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-8000 USD
CY2015Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
75000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
103000 USD
CY2014Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3320000 USD
CY2015Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3400000 USD
CY2014Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
83000 USD
CY2015Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
116000 USD
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
318000 USD
CY2014Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-124000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
446000 USD
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5742000 USD
CY2015Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7107000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
7644000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4313000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
144207000 USD
CY2015Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
253000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
347000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
48513000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
161149000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
207407000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15659000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
36606000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
131318000 USD
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
24028000 USD
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
46064000 USD
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
69475000 USD
CY2015Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
106180000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
236000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
957000 USD
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
7000 USD
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
3000 USD
CY2015Q1 us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
5304000 USD
CY2014Q3 us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
5163000 USD
us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
15954000 USD
CY2014Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8146000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
23283000 USD
CY2015Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9409000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
27146000 USD
CY2014Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
23370000 USD
CY2015Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
25385000 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
411774000 USD
CY2015Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
486957000 USD
CY2014Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
4720000 USD
CY2015Q3 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
6059000 USD
CY2014Q3 us-gaap Sales Revenue Net
SalesRevenueNet
117787000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
345570000 USD
CY2015Q3 us-gaap Sales Revenue Net
SalesRevenueNet
136992000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
402166000 USD
CY2014Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
46986000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
140089000 USD
CY2015Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
53829000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
160624000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
5211000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
6935000 USD
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2647000 shares
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
12.34
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
853000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
16750000 USD
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
2757000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
8696000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
311000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2514000 shares
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.73
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
9.88
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
8.23
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
8.73
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
26096000 USD
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4854000 shares
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6538000 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
14.50
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
18.85
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
23.28
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
2787000 USD
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
3891000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
8.30
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
16.80
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
24.82
CY2014Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
1661000 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
5211000 USD
CY2015Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
2406000 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
7075000 USD
CY2015Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
23309000 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y9M18D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y8M12D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P9Y1M6D
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
519000 shares
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4313000 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
585454000 USD
CY2015Q3 us-gaap Stockholders Equity
StockholdersEquity
673917000 USD
CY2014Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
95475000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
95378000 shares
CY2015Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
96119000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
96026000 shares
CY2014Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
94399000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
94111000 shares
CY2015Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
95138000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
94970000 shares
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">Use of Estimates </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. We base our estimates, in part, on historical experience that management believes to be reasonable under the circumstances. Actual results could differ materially from those estimates. Estimates and assumptions are periodically reviewed and the effects of revisions are reflected in the consolidated financial statements in the period they are determined to be necessary. </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Significant areas that require management&#8217;s estimates include intangible assets, contingent payment liabilities, allowance for doubtful accounts, stock-based compensation, write-down for excess and obsolete inventory, useful lives of assets, the outcome of litigation, and income taxes. We are subject to risks and uncertainties due to changes in the healthcare environment, regulatory oversight, competition, and legislation that may cause actual results to differ from estimated results. </font></div></div>

Files In Submission

Name View Source Status
0001237831-15-000060-index-headers.html Edgar Link pending
0001237831-15-000060-index.html Edgar Link pending
0001237831-15-000060.txt Edgar Link pending
0001237831-15-000060-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gmed-20150930.xml Edgar Link completed
gmed-20150930.xsd Edgar Link pending
gmed-20150930_cal.xml Edgar Link unprocessable
gmed-20150930_def.xml Edgar Link unprocessable
gmed-20150930_lab.xml Edgar Link unprocessable
gmed-20150930_pre.xml Edgar Link unprocessable
gmed9301510q.htm Edgar Link pending
gmed93015ex311.htm Edgar Link pending
gmed93015ex312.htm Edgar Link pending
gmed93015ex32.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending